New Technology Revolutionizes Disinfection Method to Reduce Spread of Deadly “Superbugs” in Medical Facilities

Bio-Intervention Specialists Offers a New Approach for Terminal Disinfection

DENVER--(BUSINESS WIRE)-- Hospital-acquired infections are one of the largest challenges affecting both the safety of patient care and the skyrocketing costs of health care, with these infections being the fourth leading cause of death in the United States and costing between $28 billion and $33 billion each year. The recent “National Healthcare Quality Report” confirmed that despite targeted infection control efforts, hospital-acquired infections remain the most common complication of hospital care.

Given these grim facts, it is even more surprising that methods used to clean infectious patient rooms – known as “terminal disinfection” – have not changed in decades. Most health care facilities still rely on their environmental services staff to clean potentially contaminated rooms by using a rag to wipe down the area with legacy chemicals such as bleach or quats (quaternary ammonium compounds). This outdated method of disinfecting a room is inconsistent, subject to human error, potentially toxic and – perhaps most importantly – often does not kill the most deadly microorganisms that can then mutate into antibiotic-resistant “superbugs.”

Some infectious microbes can live on surfaces in a hospital room for months if the surface is not properly disinfected, infecting patient after patient. Notably, research published in Infection Control and Hospital Epidemiology provides evidence that patients admitted into a room formerly occupied by an infectious patient have double the risk of acquiring that same infection. On average, 51 percent of targeted surfaces are routinely left untouched during terminal cleans, as demonstrated in a 2008 study evaluating 23 acute care hospitals.

“Obviously, much more sophisticated and effective methods of terminal disinfection are required to protect patients and address today’s health care facility infection challenges,” said Dan Perlman, MD, a board-certified physician in infectious diseases and an advisor to Bio-Intervention Specialists™, a Colorado-based company employing the newest technology to improve disinfection protocols at hospitals and long-term care facilities.

In response to this growing epidemic, Bio-Intervention Specialists has launched Electro-BioCide™, an environmentally friendly, non-toxic and non-corrosive disinfectant that uses a radically different kill mechanism to achieve a scientifically proven 6-log kill (>99.9999% effective rate) against multiple pathogenic organisms. Certified third-party toxicity testing identified Electro-BioCide as an EPA Category IV product – the least toxic rating possible for disinfectants. Due to its Category IV EPA classification, unlike most legacy hospital disinfectants, Electro-BioCide is applied using a state-of-the-art electrostatic spraying system. This unique and highly efficient method vastly reduces the volume of product used and provides consistent and thorough coverage of surfaces.

“We are excited to offer health care facilities a next-generation disinfection technology that offsets the challenges associated with current cleaning techniques and legacy chemicals,” said Tom Boyer, president and CEO of Bio-Intervention Specialists. “Electro-BioCide finally provides the industry with a modern, cost-effective alternative to the antiquated spray bottle, rag and legacy chemicals that are far too common today.”

Bio-Intervention Specialists is now offering the “Bio-Intervention Terminal Disinfection Toolkit™” to address all of the variables contributing to ineffective terminal disinfections. This toolkit is designed to offer a cost-effective option that allows health care facilities access to 21st Century disinfection techniques and technology via a comprehensive, integrated disinfection program that can be managed through the hospital’s existing staff. The Bio-Intervention Terminal Disinfection Toolkit includes training and certification on advanced terminal disinfection techniques that utilize a scientifically proven protocol and includes the application of Electro-BioCide with a state-of-the-art electrostatic spraying system.

Facilities adopting the Bio-Intervention Terminal Disinfection Toolkit will also have first priority access to Bio-Intervention Specialists’ rapid-response, nationwide, on-site disinfection service. This service is performed by certified Bio-Intervention technicians and is available for health care facilities requiring additional, short-term support.

About Electro-BioCide™

Unlike legacy disinfectants that typically poison microorganisms, Electro-BioCide eliminates pathogens via a revolutionary kill process that is nearly 100 percent effective. Photographs captured by a scanning electron microscope reveal an almost complete disintegration of the bacterial cell wall when exposed to Electro-BioCide, making the mutation of microorganisms and the development of resistance nearly impossible. Electro-BioCide destroys a broad spectrum of microorganisms (>99.9999% effectiveness), including MRSA, VRE, Acinetobacter baumannii, Klebsiella pneumoniae, VRSA, Campylobacter jejuni, Trichophyton mentagrophates and Pseudomonas aeruginosa, and is highly effective against Clostridium difficile spores (>99.9997% effectiveness). Electro-BioCide is applied using an electrostatic spray system that maximizes product coverage on surfaces to further improve the terminal disinfection process.

About Bio-Interventional Specialists™

Bio-Intervention Specialists was founded to develop next-generation scientific solutions that address the need to save lives and reduce costs through improved hospital clinical outcomes. Using an innovative bio-intervention process and a new application for electrostatic spraying technology, Bio-Intervention Specialists’ products and services offer next-generation options to comprehensively disinfect environmental surfaces and help decrease the incidence and cost of hospital-acquired infections.



CONTACT:

Performance PR & Marketing
Kimberly Langston, 303-916-9539
[email protected]

KEYWORDS:   United States  North America  Colorado

INDUSTRY KEYWORDS:   Health  Hospitals  Infectious Diseases  Medical Supplies  General Health

MEDIA:

Logo
 Logo